0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

1
Letter to the Editor   |    
Dr. Kéri Replies
Szabolcs Kéri, M.D., Ph.D., D.Sc.
Am J Psychiatry 2010;167:719-719. doi:10.1176/appi.ajp.2010.10010103r
View Author and Article Information
Budapest, Hungary

The author's disclosures accompany the original article.

Accepted March , 2010.

Copyright © American Psychiatric Association

To the Editor: We thank Dr. Lang for her insightful comments. She raises the possibility that second-generation antipsychotics, such as clozapine and olanzapine, may normalize P50 suppression via a specific activating effect on the AKT/glycogen synthase kinase-3β messenger system. The main purpose of our study was to investigate the relationship between P50 suppression and AKT-phosphorylation in never-medicated patients with schizophrenia in order to exclude the potential confounding effect of medications. Our study was not designed to investigate the specific effect of different antipsychotics. The most convincing evidence for a differential effect of second- versus first-generation antipsychotics on P50 suppression and AKT-phosphorylation would come from randomized controlled trials. However, it must be mentioned that we previously observed decreased neuregulin 1-induced AKT-phosphorylation in patients with schizophrenia receiving second-generation antipsychotics (1), suggesting that these drugs do not completely normalize the AKT/glycogen synthase kinase-3β pathway. Further studies are warranted to clarify this issue with the parallel assessment of sensory endophenotypes and molecular mechanisms.

Kéri  S;  Seres  I;  Kelemen  O;  Benedek  G:  Neuregulin 1-stimulated phosphorylation of AKT in psychotic disorders and its relationship with neurocognitive functions.  Neurochem Int 2009; 55:606—609
[CrossRef] | [PubMed]
 
References Container
+

References

Kéri  S;  Seres  I;  Kelemen  O;  Benedek  G:  Neuregulin 1-stimulated phosphorylation of AKT in psychotic disorders and its relationship with neurocognitive functions.  Neurochem Int 2009; 55:606—609
[CrossRef] | [PubMed]
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 20.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 20.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 26.  >
The American Psychiatric Publishing Textbook of Psychiatry, 5th Edition > Chapter 26.  >
Manual of Clinical Psychopharmacology, 7th Edition > Chapter 1.  >
Topic Collections
Psychiatric News
Read more at Psychiatric News >>
APA Guidelines